Clinical actionability enhanced through deep targeted sequencing of solid tumors.

MLA

Chen, Ken, et al. “Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors.” Clinical Chemistry, vol. 61, no. 3, Mar. 2015, pp. 544–53. EBSCOhost, https://doi.org/10.1373/clinchem.2014.231100.

APA

Chen, K., Meric-Bernstam, F., Zhao, H., Zhang, Q., Ezzeddine, N., Tang, L.-Y., Qi, Y., Mao, Y., Chen, T., Chong, Z., Zhou, W., Zheng, X., Johnson, A., Aldape, K. D., Routbort, M. J., Luthra, R., Kopetz, S., Davies, M. A., de Groot, J., … Eterovic, A. K. (2015). Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clinical Chemistry, 61(3), 544–553. https://doi.org/10.1373/clinchem.2014.231100

Chicago

Chen, Ken, Funda Meric-Bernstam, Hao Zhao, Qingxiu Zhang, Nader Ezzeddine, Lin-Ya Tang, Yuan Qi, et al. 2015. “Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors.” Clinical Chemistry 61 (3): 544–53. doi:10.1373/clinchem.2014.231100.